CapsoVision (CV) EBIT Margin (2024 - 2025)
CapsoVision's (CV) quarterly EBIT Margin came in at 190.51% in Q4 2025, down 5626.0% year-on-year from 3.45% in Q4 2024, and up 15.95% quarter-over-quarter from 226.65% in Q3 2025.
CapsoVision (CV) EBIT Margin (2024 - 2025) Analysis & Trends
CapsoVision has disclosed EBIT Margin across 2 years of filings, most recently posting 190.51% for Q4 2025.
- EBIT Margin for Q4 2025 came in at 190.51%, down 5626.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 174.14% (changed N/A YoY), and the FY2025 annual result was 188.25%, down 1883.0% from the prior year.
- EBIT Margin came in at 190.51% for Q4 2025 at CapsoVision, up from 226.65% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 134.24% in Q4 2024 to a low of 226.65% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.04% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.42% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.94% |
| 10 | CapsoVision | 176.55 Mn | 166.44 Mn | 1.95 Mn | -190.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -190.51% |
| Sep 30, 2025 | -226.65% |
| Jun 30, 2025 | -140.30% |
| Dec 31, 2024 | -134.24% |
| Sep 30, 2024 | -195.65% |
| Jun 30, 2024 | -185.40% |